Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY18.88 CNY
Change Today -0.18 / -0.94%
Volume 14.1M
002365 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

qianjiang yongan pharm-a (002365) Snapshot

Open
CNY18.00
Previous Close
CNY19.06
Day High
CNY19.35
Day Low
CNY17.15
52 Week High
06/15/15 - CNY34.60
52 Week Low
07/7/14 - CNY9.48
Market Cap
3.5B
Average Volume 10 Days
11.4M
EPS TTM
CNY0.19
Shares Outstanding
187.0M
EX-Date
--
P/E TM
99.5x
Dividend
CNY0.06
Dividend Yield
0.16%
Current Stock Chart for QIANJIANG YONGAN PHARM-A (002365)

Related News

No related news articles were found.

qianjiang yongan pharm-a (002365) Related Businessweek News

No Related Businessweek News Found

qianjiang yongan pharm-a (002365) Details

Qianjiang Yongan Pharmaceutical Co., Ltd. engages in the production and distribution of taurine products in China and internationally. It offers its products primarily for application in nutrition and health products, food additives, and other areas. The company was founded in 2001 and is based in Qianjiang, China.

Founded in 2001

qianjiang yongan pharm-a (002365) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

qianjiang yongan pharm-a (002365) Key Developments

Qianjiang Yongan Pharmaceutical Seeks Acquisitions

Qianjiang Yongan Pharmaceutical Co., Ltd. (SZSE:002365) plans to invest CNY 100 million to set up investment management unit.

Qianjiang Yongan Pharmaceutical Co., Ltd. Approves Amendments to Articles of Association

Qianjiang Yongan Pharmaceutical Co., Ltd. at its AGM held on June 09, 2015, approved amendments to the articles of association of the company.

Qianjiang Yongan Pharmaceutical Co., Ltd. Approves the Cash Dividend for 2014; Announces Executive Appointments

Qianjiang Yongan Pharmaceutical Co., Ltd. at its AGM held on June 9, 2015, approved the cash dividend of CNY 0.60 per 10 shares tax included for the year 2014. The company also announced the appointment of Wu Yuxi, and Ding Hongli as director. Wang Yonghai, Wang Dahong and Sun Xinsheng as independent director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002365:CH CNY18.88 CNY -0.18

002365 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002365.
View Industry Companies
 

Industry Analysis

002365

Industry Average

Valuation 002365 Industry Range
Price/Earnings 100.0x
Price/Sales 6.3x
Price/Book 3.7x
Price/Cash Flow 104.9x
TEV/Sales 5.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QIANJIANG YONGAN PHARM-A, please visit www.chinataurine.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.